Cargando…
Reducing morbidity and mortality in high risk patients with statins
Residual coronary heart disease remains a significant problem even after adequate statin therapy for cardiovascular risk reduction as currently recommended by the Adult Treatment Panel III (ATP-III) of the National Cholesterol Education Program (NCEP). This is particularly true for the high risk pat...
Autores principales: | Singh, Vibhuti, Deedwania, Prakash |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697584/ https://www.ncbi.nlm.nih.gov/pubmed/19554090 |
Ejemplares similares
-
Benefits of statin therapy and compliance in high risk cardiovascular patients
por: Lardizabal, Joel A, et al.
Publicado: (2010) -
Low high-density lipoprotein cholesterol: current status and future strategies for management
por: Singh, Vibhuti, et al.
Publicado: (2010) -
The Anti-Ischemic and Anti-Anginal Properties of Statins
por: Lardizabal, Joel A., et al.
Publicado: (2010) -
Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study
por: Kwong, Jeffrey C., et al.
Publicado: (2009)